Oragenics Inc. (OGEN) intrinsic value & 10-year financials
Oragenics Inc. (OGEN) has a Graham intrinsic value of $235.73 per share. At $0.43 on Oct 17, 2026, the stock trades 100% below that value.
- Graham intrinsic value
- $235.73
- Share price (Oct 17, 2026)
- $0.43
- Price vs Graham value
- 100% below
- Market cap
- $938.1K
- Revenue (FY2025)
- —
- Revenue growth (10-yr CAGR)
- -34.2%
- ROIC (10-yr avg)
- 1128.9%
- Free cash flow (FY2025)
- —
OGEN 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | — | -$9.8M | -$4.56 | — | — | -228.9% |
| FY2024 | — | -$10.6M | -$1.60 | — | — | -714.9% |
| FY2023 | $37.7K | -$20.7M | -$3.06 | — | -55519.9% | -1190.6% |
| FY2022 | $131.5K | -$14.3M | -$2.37 | -$15.4M | -10960.7% | -2277.1% |
| FY2021 | $87.0K | -$15.7M | — | -$13.5M | -18130.3% | 4022.6% |
| FY2020 | — | -$26.4M | — | — | — | 7927.1% |
| FY2019 | — | -$15.6M | — | -$13.0M | — | 4257.1% |
| FY2018 | — | -$9.9M | — | -$9.2M | — | -73.5% |
| FY2017 | $0 | -$6.7M | — | — | — | -144.8% |
| FY2016 | $0 | -$7.0M | — | -$7.1M | — | -288.0% |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
ORAGENICS INC revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
ORAGENICS INC has historically struggled to out-earn its cost of capital, averaging just -10.3% ROIC.
ORAGENICS INC capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, ORAGENICS INC is modeled at -34.2% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $235.73 per share.